Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Greenwich LifeSciences Inc | GLSI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.34 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.34 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 7.58 - 21.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 12.34 | USD |
Greenwich LifeSciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 157M | 12.85M | - | 0 | -7.83M | -0.61 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Greenwich LifeSciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLSI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.75 | 13.38 | 11.375 | 12.61 | 39,896 | -0.41 | -3.22% |
| 1 Month | 20.43 | 20.43 | 11.375 | 15.08 | 37,697 | -8.09 | -39.60% |
| 3 Months | 8.88 | 21.44 | 8.00 | 14.47 | 54,698 | 3.46 | 38.96% |
| 6 Months | 7.88 | 21.44 | 7.58 | 13.28 | 35,002 | 4.46 | 56.60% |
| 1 Year | 10.87 | 21.44 | 7.58 | 12.18 | 26,551 | 1.47 | 13.52% |
| 3 Years | 35.56 | 48.96 | 6.8241 | 18.39 | 70,461 | -23.22 | -65.30% |
| 5 Years | 5.00 | 158.07 | 3.262 | 36.96 | 162,936 | 7.34 | 146.80% |
Greenwich LifeSciences Description
| Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. |
